Collectively, results of the IL-10R blockade study showed that IL-10 plays a role in attenuating the level of lung inflammation, as well as in decreasing CD4+ T cell proliferation and the Th1 response in B cell-deficient mice during the chronic phase of infection. Here, IL10RA is linked to infection.